BriDGE TECHNOLOGY

 

REGENERATIVE MEDICINE

Our BriDGE technology transforms widely available intact collagen tissue into a stabilized collagen matrix that activates, supports and accelerates the patient’s own healing cascade.  A landmark study published by the Regenerative Medicine Center at the Ohio State University reported that BriDGE-processed collagen recruited host growth factors while also upregulating the host’s natural immune system to prevent biofilm formation.

 

CREATING A STABILIZED ACELLULAR COLLAGEN MATRIX

Our BriDGE® technology is a patented method to treat intact tissue, sourced from animals or humans, to create a collagen matrix with the following properties:
 

  • Extremely bio-friendly when put in contact with damaged ligaments and tendon … no long-term inflammatory response;
     

  • Recruits and supports the patient’s own growth factors directly at the wound site … 24/7;
     

  • The patient’s own growth factors are perfectly designed to stimulate cell proliferation, wound healing and cellular differentiation;
     

  • The BriDGE® technology also stabilizes the collagen matrix to prevent premature degradation … it is there to support tissue regeneration until the wound heals.